Author

Colleen E. Bauza

Observed names: C., Bauza, COLLEEN BAUZA, Colleen Bauza

Observed institutions: Jaeb Center for Health Research, Stanford University

ORCID: 0000-0002-7569-2051

Observed ORCID: 0000-0002-7569-2051

OpenAlex ID: A5011848164

Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes

2023 · Gregory P. Forlenza, Jennifer McVean, et al. · JAMA · 169

Real-World, Patient-Reported and Clinic Data from Individuals with Type 1 Diabetes Using the MiniMed 670G Hybrid Closed-Loop System

2021 · Stephanie N. DuBose, Colleen Bauza, et al. · Diabetes Technology & Therapeutics · 20

Diabetes Endothelial Keratoplasty Study: Methods and Impact on the Use of Corneas From Donors With Diabetes for Descemet Membrane Endothelial Keratoplasty

2025 · Marianne O. Price, Loretta B. Szczotka-Flynn, et al. · Cornea · 12

Donor Diabetes and 1-Year Descemet Membrane Endothelial Keratoplasty Success Rate

2025 · Francis W. Price, Loretta B. Szczotka-Flynn, et al. · JAMA Ophthalmology · 8

Use of the Community-Derived Open-Source Automated Insulin Delivery Loop System in Type 2 Diabetes

2024 · Colleen Bauza, Lauren G. Kanapka, et al. · Diabetes Technology & Therapeutics · 7

Continuous Glucose Monitoring Provides Durable Glycemic Benefit in Adolescents and Young Adults with Type 1 Diabetes: 12-Month Follow-Up Results

2023 · Kellee M. Miller, Colleen Bauza, et al. · Pediatric Diabetes · 5

Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial

2023 · Laurel H. Messer, Colleen Bauza, et al. · Pediatric Diabetes · 5

Associations of CGM Metrics With Stimulated C-Peptide Measures in Youth With Recent-Onset Type 1 Diabetes

2025 · Anna Neyman, Linda A. DiMeglio, et al. · Diabetes Care · 4

Patients with Type 2 Diabetes and Residual Insulin Secretory Capacity Realize Glycemic Benefits from Real-Time Continuous Glucose Monitoring

2021 · Sarah Puhr, John B. Welsh, et al. · Journal of Diabetes Science and Technology · 4

Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experience

2024 · Laya Ekhlaspour, Bruce Buckingham, et al. · Journal of Clinical & Translational Endocrinology · 2

Associations of CGM Metrics with Stimulated C-Peptide Measures in Youth with Recent-Onset Type 1 Diabetes

2025 · Anna Neyman, Linda A. DiMeglio, et al. · 1

898-P: Benefit of Continuous Glucose Monitoring (CGM) in Reducing Hemoglobin A1c Is Sustained through 12 Months of Use among Adolescents and Young Adults with Type 1 Diabetes (T1D)

2020 · KELLEE MILLER, LAUREN KANAPKA, et al. · Diabetes · 1

890-P: Durability of Continuous Glucose Monitoring (CGM) Use in Young Children, Teens, and Young Adults with Type 1 Diabetes (T1D)

2020 · DANIEL DESALVO, LAUREN KANAPKA, et al. · Diabetes · 1

Supplementary Material for: Impact of Early Initiation of Automated Insulin Delivery on Glycemia Two Years from Type 1 Diabetes Diagnosis

2026 · karger, figshare admin, M., VanName, et al. · Figshare

Associations of CGM Metrics with Stimulated C-Peptide Measures in Youth with Recent-Onset Type 1 Diabetes

2025 · Anna Neyman, Linda A. DiMeglio, et al.

717-P: Real-World, Patient-Reported Data on Training and Use of 670G Hybrid Closed-Loop (HCL) among Children and Adults with Type 1 Diabetes (T1D)

2021 · COLLEEN BAUZA, STEPHANIE DUBOSE, et al. · Diabetes

Works count: 16

Citation count: 239

H-index: 5

I10-index: 3